lyntia Leads Quantum Key Distribution (QKD) Coalition Test
The group’s primary objective was to secure a fiber link from Digital Realty’s data center, a crucial step in demonstrating the compatibility of quantum cryptography with a new, very low-latency fiber technology.
During its test with critical partners, two versions of QKD technology from the two manufacturers LuxQuanta (CV-QKD) and ID Quantique (DV-QKD), along with a Quantum Key Management System (QKMS) from evolutionQ, were used to protect data center access connections.
Another key element of this trial was its use of hollow-core fiber technology. Hollow-core fibers guide light in a hollow core, making this unique waveguide ideal for sensing, imaging, and ultrashort pulse applications.
Vanesa Díaz, CEO of LuxQuanta, said the trial shows the utility of quantum cryptography to secure optical links that connect data centers.“We have showcased the interoperability of our product, NOVA LQ®, by integrating it with our partners’ systems and proving its ability to coexist in the same optical band as data, even over low-latency fibers,” she said. “This ensures secure and efficient transmission within existing optical networks.” .
Make-in-India Enabler for Quantum Communications and Silicon Photonics Announced
STL (NSE: STLTECH), a leading optical and digital solutions company, debuted its revolutionary MultiCore Fibre (MCF) in October 17 news release STL also showcased the power of this optical fibre innovation through a live 400G network transmission with real-time traffic simulation. This Make-In-India innovation is laying the groundwork for the scale-up of advanced technologies like quantum communications and silicon photonics.
Inaugurating the multicore fibre solution at STL’s booth, Sri Neeraj Mittal, Secretary of the Department of Telecommunications, said, “STL’s multicore solution aims to solve the problems of transmission capacity per fibre. It will fulfil requirements for advanced technologies like quantum communications and silicon photonics.”
STL’s Multicore fibre leverages Space Division Multiplexing in 7 and 4 core fibre to achieve ultra-high transmission capacity per fibre within the same diameter. This marquee fibre was deployed in the Advanced Optical Communications (AOC) Test Bed project last year to evaluate its transmission performance with advanced technologies in on-field conditions. This project is run in collaboration with DoT and IIT Chennai.
Dynex, a provider of quantum computing solutions, announced on October 17 its 10-year roadmap, outlining the company’s transition from emulated quantum computing to silicon quantum chips as reported by Parth at TechPlugged . The strategy positions Dynex at the forefront of the quantum industry, aiming to capture a 25% quantum computing market share by 2034. In parallel, Dynex has also kicked off a $50 million venture capital round to fuel its growth, targeting strategic top-tier industry players and leading venture capitalists.
The roadmap includes:
- Quantum Nodes: One of the first steps in Dynex’s evolution is the introduction of Quantum Nodes, a distributed computing infrastructure that allows users to deploy high-performance quantum emulation software.
- Silicon Quantum Chip Rollout: Dynex is soon to launch its first Apollo Silicon Quantum Chip by 2025, featuring 1,000 qubits and 1,000 quantum gates. Over the next decade, the platform will also release advanced product versions, These advancements aim to enable real-time quantum computations, opening new possibilities in industries requiring high-speed problem solving, from drug discovery to cryptography.
- Ethical Integrity at Scale: A cornerstone of Dynex’s roadmap has been and is its unwavering commitment to upholding ethics in quantum computing.
In Other News: Forbes Reports “How Quantum Computing Is Accelerating Drug Discovery And Development”
Merck and HQS Quantum Simulations are working on quantum chemical applications for faster, more cost-effective drug discovery. Similarly, the Cleveland Clinic has partnered with IBM to install the first quantum computer dedicated to healthcare research. This machine will explore new treatments and advance biomedical research, further solidifying quantum computing’s role in healthcare innovation.
Key areas of development are:
Unlocking Personalized Medicine
Molecular Simulations
Quantum Computing And Protein Folding
New Frontiers In Material Science
Collaboration And Ecosystem Development
Impact On Regulatory Processes
Boger believes that growing investments in quantum technologies suggest a bright future for drug discovery and innovation. and he also explains how drug development teams should:
• Invest in quantum expertise. Develop in-house quantum capabilities or collaborate with experts.
• Prioritize immediate use cases. Focus on high-impact applications like molecular simulations.
• Join co-design programs for quantum error correction. Engage in initiatives for early access to precise simulations.
• Prepare for regulatory and security changes. Stay informed about regulations and invest in quantum-safe encryption.